ArticleCellular and molecular neurobiology2020
COVID-19, Angiotensin Receptor Blockers, and the Brain.
Article in Cellular and molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Combined ACEI and ARB therapy and ICU mortality in critically ill COVID-19 patients: a retrospective cohort study.Frontiers in pharmacology · 2026Article
- Effects of COVID-19 on Synaptic and Neuronal Degeneration.Brain sciences · 2023Review
- The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021Article
- Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021Review
- Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective.BMC infectious diseases · 2021Article
- A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19.Journal of psychosomatic research · 2021Review
- A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View.Molecular neurobiology · 2021Review
- Candesartan could ameliorate the COVID-19 cytokine storm.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020Article
- Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.Pharmacological research · 2020Article
- So-called Urinary Tract Infection in the Era of COVID-19.Journal of the American Geriatrics Society · 2020Article
- Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.Chaos (Woodbury, N.Y.) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.